Sarah Laurenzano
Pediatric Endocrinology · Springfield, MANPI 1184068082
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.1% of the total across 111 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 19 manufacturers, the largest accounting for just 23.0% — the pattern of someone who eats at a lot of different presentations.
Across 111 payments — averaging $33.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Insulet Corporation$848
- Novo Nordisk$437
- AstraZeneca$325
- Ipsen Biopharmaceuticals, Inc$281
- Abbott$273
- Ascendis Pharma Endocrinology Inc$268
- plus $1K from 13 others
Across 11 payments — averaging $2453.91 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Janssen Research & Development, LLC$27K
What the payments were for
- Food & beverage$3,66099%
- Education$321%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Insulet Corporation | 40 | $848 |
| Novo Nordisk | 14 | $437 |
| AstraZeneca | 4 | $325 |
| Ipsen Biopharmaceuticals, Inc | 9 | $281 |
| Abbott | 4 | $273 |
| Ascendis Pharma Endocrinology Inc | 4 | $268 |
| Ferring Pharmaceuticals Inc. | 8 | $210 |
| Neurocrine Biosciences, Inc. | 2 | $183 |
| Medtronic | 5 | $159 |
| Endo Pharmaceuticals Inc. | 2 | $154 |
| Sanofi-aventis U.S. LLC | 1 | $100 |
| Pfizer | 1 | $98 |
| AbbVie | 4 | $77 |
| Tandem Diabetes Care, Inc. | 4 | $70 |
| Lilly USA, LLC | 2 | $68 |
| Xeris Pharmaceuticals, Inc. | 3 | $59 |
| Dexcom, Inc. | 2 | $35 |
| Arbor Pharmaceuticals, Inc. | 1 | $25 |
| BETA Bionics, Inc. | 1 | $22 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- CRENESSITY$154
- Strensiq$146
- SUPPRELIN$126
- Omnipod$125
- FREESTYLE LIBRE 3$124
- SKYTROFA$122
- MINIMED 780G$113
How this compares
$3,692 in reported general payments places this provider in the 80th percentile of 64 pediatric endocrinology providers in Massachusetts.
See all pediatric endocrinology providers in Massachusetts →
Other pediatric endocrinology in Springfield
- Michelle KayserSpringfield$1K
- Bracha GoldsweigSpringfield$180
- Holley AllenSpringfield$156
- Lori LaffelBoston$285K
- Joseph WolfsdorfBoston$51K
- Lynne LevitskyBoston$22K
- Stuart BrinkWaltham$15K
- Benjamin NwosuWorcester$11K
- Amy SeagrovesBoston$10K
- Katharine GarveyBoston$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.